Cited 0 time in webofscience Cited 0 time in scopus

The level of autoantibodies targeting eukaryote translation elongation factor 1 Alpha1 and ubiquitin-conjugating enzyme 2L3 in nondiabetic young adults

Title
The level of autoantibodies targeting eukaryote translation elongation factor 1 Alpha1 and ubiquitin-conjugating enzyme 2L3 in nondiabetic young adults
Authors
Kim, E.G.[Kim, Eun Hee G.]Kwak, S.H.[Kwak, Soo Heon]Hwang, D.[Hwang, Dae Hee]Yi, E.C.[Yi, Eu Gene C.]Park, K.S.[Park, Kyong Soo]Koo, B.K.[Koo, Bo Kyung]Kim, K.M.[Kim, Kristine M.]
DGIST Authors
Hwang, D.[Hwang, Dae Hee]
Issue Date
2016
Citation
Diabetes and Metabolism Journal, 40(2), 154-160
Type
Article
Article Type
Article
Keywords
AdultAge DistributionAgedAntibody DetectionAntigenic VariationAutoantibodiesAutoantibodyAutoimmune DiseaseControlled StudyDiabetes Mellitus, Type 1Enzyme Linked Immunosorbent AssayEukaryote Translation Elongation Factor 1 Alpha 1 AutoantibodyFemaleGlutamate Decarboxylase AntibodyGlycosylated HemoglobinHumanInitiation Factor 1AInitiation Factor 1A AutoantibodyInsulin Dependent Diabetes MellitusMajor Clinical StudyMaleOnset AgePrevalenceProtein MicroarrayUbiquitin-Conjugating Enzyme 2L3 AutoantibodyUbiquitin Conjugating EnzymeUbiquitin Conjugating Enzyme 2L3Ubiquitin Conjugating Enzyme 2L3 AutoantibodyUnclassified DrugYoung Adult
ISSN
2233-6079
Abstract
Background: The prevalence of novel type 1 diabetes mellitus (T1DM) antibodies targeting eukaryote translation elongation factor 1 alpha 1 autoantibody (EEF1A1-AAb) and ubiquitin-conjugating enzyme 2L3 autoantibody (UBE2L3-AAb) has been shown to be negatively correlated with age in T1DM subjects. Therefore, we aimed to investigate whether age affects the levels of these two antibodies in nondiabetic subjects. Methods: EEF1A1-AAb and UBE2L3-AAb levels in nondiabetic control subjects (n=150) and T1DM subjects (n=101) in various ranges of age (18 to 69 years) were measured using an enzyme-linked immunosorbent assay. The cutoffpoint for the presence of each autoantibody was determined based on control subjects using the formula: [mean absorbance+3×standard deviation]. Results: In nondiabetic subjects, there were no significant correlations between age and EEF1A1-AAb and UBE2L3-AAb levels. However, there was wide variation in EEF1A1-AAb and UBE2L3-AAb levels among control subjects < 40 years old; the prevalence of both EEF1A1-AAb and UBE2L3-AAb in these subjects was 4.4%. When using cutoffpoints determined from the control subjects < 40 years old, the prevalence of both autoantibodies in T1DM subjects was decreased (EEFA1-AAb, 15.8% to 8.9%; UBE2L3-AAb, 10.9% to 7.9%) when compared to the prevalence using the cutoffderived from the totals for control subjects. Conclusion: There was no association between age and EEF1A1-AAb or UBE2L3-AAb levels in nondiabetic subjects. However, the wide variation in EEF1A1-AAb and UBE2L3-AAb levels apparent among the control subjects < 40 years old should be taken into consideration when determining the cutoffreference range for the diagnosis of T1DM. © 2016 Korean Diabetes Association.
URI
http://hdl.handle.net/20.500.11750/2307
DOI
10.4093/dmj.2016.40.2.154
Publisher
Korean Diabetes Association
Related Researcher
  • Author Hwang, Dae Hee Systems Biology and Medicine Lab
  • Research Interests Multilayered spatiotemporal networks; Regulatory motifs or pathways; Metabolite-protein networks; Network stochasticity; Proteomics and informatics
Files:
There are no files associated with this item.
Collection:
New BiologyETC1. Journal Articles


qrcode mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE